Coles, woolies, sonic join ASX yield hunt

Coles and Woolworths continue to solidify their status as defensive ASX blue chips with reliable and steadily growing dividends through FY28. Coles is projected to increase its fully franked dividend from 73 cents per share in FY26 to 91 cents by FY28, representing a 17% growth and a grossed-up yield potentially reaching 6%, underpinned by strong earnings growth and operational efficiencies. Meanwhile, Woolworths is expected to raise its dividend per share by more than 10% annually through FY28, with a forward yield climbing from around 3.4% in FY27 to an estimated 4.7% including franking credits, supported by its dominant supermarket presence and diversified business model that includes Countdown and BIG W.

Telstra and Amcor stand out as compelling defensive dividend plays with attractive yields reflecting their essential roles in Australian infrastructure and supply chains. Telstra’s dividend yield is forecast around 4.2% for FY26 and FY27, bolstered by its critical telecommunications services that underpin connectivity nationwide. Amcor offers an even more enticing yield near 7% over the same period, benefiting from its stable position in packaging supply chains, making both stocks appealing for income-focused investors seeking resilience amid market volatility.

Coles’ dividend growth is supported not only by robust financial performance but also by strategic investments aimed at sustaining long-term productivity and market share. In FY26, Coles reported a 12.5% increase in underlying net profit and a 13% rise in its full-year dividend, while ramping up spending on new stores, eCommerce, and supply chain automation. Early FY27 sales trends suggest this momentum will continue, reinforcing Coles’ appeal as a mature, defensive consumer staple with a stable and fully franked dividend yield that currently trades around 3.1%.

Healthcare stocks such as Sonic Healthcare, Sigma Healthcare, and ResMed are emerging as compelling dividend and growth opportunities, driven by enduring demand in sectors like pathology, pharmacy retail, and sleep health. Sonic Healthcare, with nearly 30 years of consistent dividend increases and a FY26 dividend yield around 5.4%, benefits from demographic tailwinds and strategic acquisitions that bolster margins and expand its global footprint across nine countries. Similarly, Sigma Healthcare leverages its merger with Chemist Warehouse to enhance scale, operational efficiencies, and international expansion, while ResMed capitalizes on recurring revenue streams from underdiagnosed sleep conditions, evidenced by an 11% quarterly revenue growth and improving operating income dynamics.

Industrial and infrastructure plays like Goodman Group and Aurizon offer investors diversification beyond traditional consumer staples by tapping into structural growth trends in logistics, data centres, and commodity transport. Goodman’s strategic control of well-located industrial sites with critical power access positions it uniquely to serve the surging demand for AI-driven cloud computing infrastructure, with over $14 billion in data centre projects underway and a power bank expanding to 6GW. Aurizon complements this by providing stable, high-yield income through its regulated rail infrastructure, transporting over 250 million tonnes of commodities annually and delivering a FY26 dividend yield of approximately 6.3%, underscoring the resilience of essential services in the industrial sector.

The convergence of healthcare and industrial sectors within ASX dividend stocks highlights a strategic diversification approach that balances resilient income streams with long-term growth potential. While healthcare companies address non-discretionary, demographic-driven needs such as diagnostics, pharmacy, and medical technology, industrial firms like Goodman and Aurizon capitalize on infrastructure demands fueled by urbanization, electrification, and digital transformation. This dual-sector exposure not only mitigates risks associated with traditional consumer staples but also aligns portfolios with enduring structural trends, as evidenced by Wesfarmers’ disciplined asset management and Qantas Airways’ loyalty-driven earnings that further illustrate the breadth of emerging income opportunities.

Successful dividend investing hinges on selecting companies with strong market positions and resilient earnings that can withstand economic cycles rather than merely chasing high yields. Defensive stocks such as Telstra and Woolworths exemplify this approach, offering essential services with steady demand and multiple avenues for business improvement—Telstra’s network quality and franking credits and Woolworths’ investments in loyalty and online grocery bolster dividend sustainability despite sector risks.

Balancing yield with growth requires a diversified portfolio spanning sectors like retail, healthcare, infrastructure, and financial services, where companies demonstrate both reliable dividends and reinvestment capacity. For example, Amcor’s packaging business offers around 7% dividend yields supported by essential goods demand, while Macquarie Group’s financial and infrastructure expertise provides growth despite earnings volatility. This strategic mix helps manage risk and capture long-term compounding returns.

A long-term investment mindset, especially for retirement and SMSFs, favors companies with dependable cash flows from essential services and growth potential to keep pace with rising living costs. Combining blue-chip defensive stocks like Commonwealth Bank, Coles, and Telstra with growth-oriented shares such as NextDC and ResMed allows portfolios to generate steady income while capturing emerging opportunities in digital infrastructure and healthcare, adapting as retirement approaches to emphasize income without sacrificing growth.

Investing patiently in 'boring' but essential businesses—Coles, Transurban, and Sonic Healthcare—can build serious long-term wealth through quiet compounding of earnings and dividends. These companies leverage operational efficiencies, scalable business models, and sector diversification to maintain reliable income streams and growth, with Coles notably increasing dividends by 13% in FY26 while expanding online sales and automation, illustrating how steady reinvestment in core operations supports both income and capital appreciation.

Achieving meaningful passive income from ASX dividend stocks requires substantial shareholdings and capital outlays, as illustrated by Australian Foundation Investment Co Ltd (AFIC), where generating an annual income equivalent to the Australian Age Pension of around $31,200 demands owning over 117,000 shares excluding franking credits, or about 82,000 shares when including them. AFIC’s attractive grossed-up dividend yield of 5.5% to 6.5%, combined with a low management fee of 0.16%, helps investors retain more of their returns, making it a compelling option for those targeting reliable income streams.

For investors aiming at more modest passive income targets, blue-chip stocks like Coles and Woolworths demonstrate how share quantities and investment amounts translate into dividends. To earn $1,000 annually from Coles shares in 2027, one would need roughly 1,220 shares costing about $28,500, or 854 shares if factoring in franking credits, reflecting a grossed-up dividend yield of 5%. Woolworths, with a forecasted dividend of $1.13 per share, requires around 885 shares—an investment near $35,470—to generate the same income, underscoring the capital needed even for relatively small passive income goals.

Larger passive income ambitions, such as generating $10,000 annually from Telstra dividends, necessitate significant investment, with approximately 50,000 shares costing about $249,000 needed based on a 20-cent dividend per share in FY26. However, a forecasted dividend increase to 21 cents in FY27 slightly reduces the required shares and investment to 47,600 shares and $237,000 respectively. Telstra’s stable dividend yield around 4% to 4.2% positions it as a defensive stock suitable for long-term income-focused investors.

Dividend-focused investors can also consider diversified vehicles like the Vanguard Australian Shares Index ETF (VAS), which offers a 3.1% dividend yield supported by top ASX companies such as BHP, Commonwealth Bank, and Wesfarmers. To generate $10,000 in passive income from VAS, owning approximately 2,867 units is necessary. This ETF provides a practical balance between diversification and income reliability, as dividends tend to be steadier than capital growth, making it an accessible option for those building passive income portfolios over time.

Sonic Healthcare's dividend sustainability is deeply rooted in its commanding market position as the largest private medical laboratory operator across Australia, the UK, Germany, and Switzerland, which provides a resilient operational foundation. The company's strategic focus on industry consolidation and efficiency gains, particularly in pathology where scale is critical, positions it to offset fee pressures by capturing market share from weaker competitors. This approach, combined with recent acquisitions in Switzerland and Germany and operational improvements in the UK and US, underpins margin expansion and supports reliable dividend payments.

Financially, Sonic Healthcare demonstrates stable and modest growth, with Bell Potter forecasting slight revenue and earnings increases for FY26, and the company reporting a robust 17% jump in net profit to AUD 621 million alongside a 14% rise in EPS. Trading near decade lows on EV/EBITDA and boasting a relatively low FY27e PE of around 16x compared to peers, Sonic is not only financially sound but potentially undervalued, enhancing confidence in its dividend reliability. Its long history of consistent dividend payments since 1994, with near-annual increases and a FY26 yield of 5.4%, further cements its reputation as a dependable income stock.

Sonic Healthcare’s commitment to digital transformation, exemplified by a planned AUD 90 million AI and digital overhaul over three years, is a forward-looking investment aimed at boosting productivity and operational efficiency, which is critical for sustaining dividends amid evolving market headwinds. Despite challenges such as Swiss fee cuts and UK NHS contract delays, the company’s diversified geographic footprint and strategic acquisitions like Germany’s LADR and Cairo Diagnostics provide multiple growth levers that support ongoing earnings and dividend stability.

Comparatively, other ASX dividend stocks like AMP and Commonwealth Bank present mixed pictures of dividend sustainability; AMP’s improved earnings and strong asset growth, coupled with a shareholder-friendly buy-back program, underpin its dividend capacity, whereas Commonwealth Bank faces headwinds from slowing growth and margin pressures despite a solid profit increase. This contrast highlights Sonic Healthcare’s unique blend of defensive earnings, strategic growth initiatives, and operational resilience that collectively enhance its dividend reliability in the current market environment.

Vanguard VAS and similar ETFs offer a simple, diversified path to ASX dividend income, delivering stability and lower risk compared to single-stock strategies.